Published July 13, 1993 | Version v1
Patent

Radiopharmaceutical bacteriostats

Description

A radiopharmaceutical has been prepared with a composition comprising: (a) a radioactive iodine-based radiopharmaceutical; (b) an auto radiolytic decomposition-inhibiting antioxidant selected from: (i) ascorbic acid (ii) nicotinamide, (iii) nicotinic acid, and (iv) a mixture of ascorbic acid and nicotinamide; (c) a bacteriostat selected from: (i) benzalkonium chloride, and (ii) benzethonium chloride

Availability note (English)

Patent and Trademark Office, Box 9, Washington, DC 20232 (United States).

Additional details

Publishing Information

Imprint Pagination
[10 p.].
IPC:
Int. Cl. A61K 49/02; A61K 43/00.
IPC
Int. Cl. A61K 49/02; A61K 43/00.
Patent number
US patent document 5,227,152/A/

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
24069621
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
ANTIBIOTICS; ANTIOXIDANTS; CHEMICAL COMPOSITION; CHEMICAL PREPARATION; IODINE ISOTOPES; RADIOPHARMACEUTICALS
Descriptors DEC
ANTI-INFECTIVE AGENTS; DRUGS; LABELLED COMPOUNDS; MATERIALS; ORGANIC COMPOUNDS; RADIOACTIVE MATERIALS; SYNTHESIS

Optional Information

Secondary number(s)
US patent application 7-806,572.